Search Results

You are looking at 81 - 90 of 99 items for :

Clear All
Open access

Stefano Mangiola, Ryan Stuchbery, Patrick McCoy, Ken Chow, Natalie Kurganovs, Michael Kerger, Anthony Papenfuss, Christopher M Hovens and Niall M Corcoran

weeks by 250 mg to a final dose of 1000 mg daily; bicalutamide 50 mg orally daily and prednisolone 5 mg orally twice daily for a total of 6 months (Australian New Zealand Clinical Trials Registry 12612000772842). Untreated patients with similar pre

Open access

T L C Wolters, C D C C van der Heijden, N van Leeuwen, B T P Hijmans-Kersten, M G Netea, J W A Smit, D H J Thijssen, A R M M Hermus, N P Riksen and R T Netea-Maier

Schofl C Petroff D Tonjes A Grussendorf M Droste M Stalla G Jaursch-Hancke C Stormann S Schopohl J . Incidence of myocardial infarction and stroke in acromegaly patients: results from the German Acromegaly Registry . Pituitary 2017

Open access

Nidan Qiao

Cushing’s disease . Acta Neurochirurgica 2015 158 77 – 86 . ( https://doi.org/10.1007/s00701-015-2638-7 ) 26577636 23 Baker SG Kramer BS Lindeman KS. The randomized registry trial . New England Journal of Medicine 2014 370 681

Open access

Lena-Maria Levin, Henry Völzke, Markus M Lerch, Jens-Peter Kühn, Matthias Nauck, Nele Friedrich and Stephanie Zylla

overall research project consists of two separate cohorts (SHIP and SHIP-TREND). The present study is based on data from SHIP-TREND. In SHIP-TREND, a stratified random sample of 8826 persons, aged 20–79 years, was drawn from the central population registry

Open access

Ali Abbasi

primary-care database; fasting plasma glucose ≥7.0 mmol/l, a random sample plasma glucose ≥11.1 mmol/l; or the initiation of glucose-lowering medication as retrieved from a pharmacy registry or hospital records (11) . Figure 1 Flow diagram of the

Open access

Pinaki Dutta, Bhuvanesh Mahendran, K Shrinivas Reddy, Jasmina Ahluwalia, Kim Vaiphei, Rakesh K Kochhar, Prakamya Gupta, Anand Srinivasan, Mahesh Prakash, Kanchan Kumar Mukherjee, Viral N Shah, Girish Parthan and Anil Bhansali

previously treated for acromegaly – a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults . European Journal of Endocrinology 2014 171 717 – 726 . ( doi:10.1530/EJE-14-0515 ). 5 Reed ML Merriam GR Kargi AY . Adult

Open access

Elisabet Einarsdottir, Minna Pekkinen, Kaarel Krjutškov, Shintaro Katayama, Juha Kere, Outi Mäkitie and Heli Viljakainen

referred to as obese) were identified from the Hospital’s patient registry and those fulfilling the following criteria were eligible to participate: (i) weight-for-height ratio exceeding 60% (corresponding to age and sex-specific BMI ≥99th percentile

Open access

K L Gatford, G K Heinemann, S D Thompson, J V Zhang, S Buckberry, J A Owens, G A Dekker, C T Roberts and on behalf of the SCOPE Consortium

recruiting patients in Australia, New Zealand (ACTRN12607000551493, Australian and New Zealand Clinical Trials Registry), UK and Ireland, which aims to predict and prevent the major complications of late pregnancy (54) . Women who were nulliparous with a

Open access

Hélène Lasolle, Amandine Ferriere, Alexandre Vasiljevic, Sandrine Eimer, Marie-Laure Nunes and Antoine Tabarin

, pegvisomant (PEG), is a second-line treatment which normalizes IGF-1 plasma levels in 60–70% ( 5 ) of patients in follow-up registries and up to 97% in single-center series ( 6 ). The dopamine D2-receptor agonist, cabergoline, is an alternative to 1 GSSA

Open access

Christian Høst, Anders Bojesen, Mogens Erlandsen, Kristian A Groth, Kurt Kristensen, Anne Grethe Jurik, Niels H Birkebæk and Claus H Gravholt

. The authors also wish to thank the doctors who referred their KS patients to us. References 1 Bojesen A Juul S Gravholt CH . Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study . Journal of Clinical